VentriPoint Diagnostics Ltd.
VentriPoint Diagnostics Ltd. VPTDF Peers
See (VPTDF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VPTDF | $0.09 | +3.26% | 15.00M | -4.59 | -$0.02 | N/A |
| SEMHF | $55.30 | N/A | 62.02B | 26.46 | $2.09 | +2.03% |
| SMMNY | $26.35 | -3.04% | 59.11B | 25.34 | $1.04 | +1.27% |
| RYLPF | $23.30 | -3.76% | 21.55B | 80.34 | $0.29 | +4.05% |
| SONVF | $323.26 | -0.54% | 19.27B | 29.82 | $10.84 | +1.81% |
| SONVY | $64.04 | -1.11% | 19.09B | 29.51 | $2.17 | +1.48% |
| SNNUF | $14.21 | N/A | 12.43B | 30.23 | $0.47 | +2.64% |
| CHEOY | $86.45 | -0.74% | 11.31B | 47.76 | $1.81 | +1.62% |
| CHEOF | $167.01 | -4.78% | 10.89B | 45.76 | $3.65 | +1.66% |
| WILYY | $20.20 | N/A | 8.68B | 20.20 | $1.00 | N/A |
Stock Comparison
VPTDF vs SEMHF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SEMHF has a market cap of 62.02B. Regarding current trading prices, VPTDF is priced at $0.09, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SEMHF's P/E ratio is 26.46. In terms of profitability, VPTDF's ROE is +2.34%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, VPTDF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SMMNY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SMMNY has a market cap of 59.11B. Regarding current trading prices, VPTDF is priced at $0.09, while SMMNY trades at $26.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SMMNY's P/E ratio is 25.34. In terms of profitability, VPTDF's ROE is +2.34%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, VPTDF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs RYLPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, RYLPF has a market cap of 21.55B. Regarding current trading prices, VPTDF is priced at $0.09, while RYLPF trades at $23.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas RYLPF's P/E ratio is 80.34. In terms of profitability, VPTDF's ROE is +2.34%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, VPTDF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SONVF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SONVF has a market cap of 19.27B. Regarding current trading prices, VPTDF is priced at $0.09, while SONVF trades at $323.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SONVF's P/E ratio is 29.82. In terms of profitability, VPTDF's ROE is +2.34%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, VPTDF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SONVY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SONVY has a market cap of 19.09B. Regarding current trading prices, VPTDF is priced at $0.09, while SONVY trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SONVY's P/E ratio is 29.51. In terms of profitability, VPTDF's ROE is +2.34%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, VPTDF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SNNUF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SNNUF has a market cap of 12.43B. Regarding current trading prices, VPTDF is priced at $0.09, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, VPTDF's ROE is +2.34%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, VPTDF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CHEOY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CHEOY has a market cap of 11.31B. Regarding current trading prices, VPTDF is priced at $0.09, while CHEOY trades at $86.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CHEOY's P/E ratio is 47.76. In terms of profitability, VPTDF's ROE is +2.34%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, VPTDF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CHEOF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CHEOF has a market cap of 10.89B. Regarding current trading prices, VPTDF is priced at $0.09, while CHEOF trades at $167.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CHEOF's P/E ratio is 45.76. In terms of profitability, VPTDF's ROE is +2.34%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, VPTDF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs WILYY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, WILYY has a market cap of 8.68B. Regarding current trading prices, VPTDF is priced at $0.09, while WILYY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas WILYY's P/E ratio is 20.20. In terms of profitability, VPTDF's ROE is +2.34%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, VPTDF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs WILLF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, VPTDF is priced at $0.09, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas WILLF's P/E ratio is 19.11. In terms of profitability, VPTDF's ROE is +2.34%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, VPTDF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs GNGBF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, VPTDF is priced at $0.09, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, VPTDF's ROE is +2.34%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, VPTDF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs GNGBY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, GNGBY has a market cap of 5.25B. Regarding current trading prices, VPTDF is priced at $0.09, while GNGBY trades at $19.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas GNGBY's P/E ratio is 34.23. In terms of profitability, VPTDF's ROE is +2.34%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, VPTDF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs AMBBY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, AMBBY has a market cap of 4.06B. Regarding current trading prices, VPTDF is priced at $0.09, while AMBBY trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas AMBBY's P/E ratio is 73.10. In terms of profitability, VPTDF's ROE is +2.34%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, VPTDF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs AMBFF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, VPTDF is priced at $0.09, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, VPTDF's ROE is +2.34%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, VPTDF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs NHNKY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, NHNKY has a market cap of 3.88B. Regarding current trading prices, VPTDF is priced at $0.09, while NHNKY trades at $11.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas NHNKY's P/E ratio is 20.49. In terms of profitability, VPTDF's ROE is +2.34%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, VPTDF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs NHNKF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, VPTDF is priced at $0.09, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, VPTDF's ROE is +2.34%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, VPTDF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs VTRLY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, VPTDF is priced at $0.09, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, VPTDF's ROE is +2.34%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, VPTDF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs STSEY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, VPTDF is priced at $0.09, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas STSEY's P/E ratio is 39.41. In terms of profitability, VPTDF's ROE is +2.34%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, VPTDF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs GNNDY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, GNNDY has a market cap of 1.97B. Regarding current trading prices, VPTDF is priced at $0.09, while GNNDY trades at $40.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas GNNDY's P/E ratio is 16.24. In terms of profitability, VPTDF's ROE is +2.34%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, VPTDF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs GGNDF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, VPTDF is priced at $0.09, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas GGNDF's P/E ratio is 15.66. In terms of profitability, VPTDF's ROE is +2.34%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, VPTDF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs OSSFF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, VPTDF is priced at $0.09, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, VPTDF's ROE is +2.34%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, VPTDF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DWRKF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, VPTDF is priced at $0.09, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, VPTDF's ROE is +2.34%, compared to DWRKF's ROE of N/A. Regarding short-term risk, VPTDF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MCRPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, VPTDF is priced at $0.09, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, VPTDF's ROE is +2.34%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, VPTDF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SSII Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SSII has a market cap of 1.71B. Regarding current trading prices, VPTDF is priced at $0.09, while SSII trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SSII's P/E ratio is -110.25. In terms of profitability, VPTDF's ROE is +2.34%, compared to SSII's ROE of -1.33%. Regarding short-term risk, VPTDF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs OSSUY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, VPTDF is priced at $0.09, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, VPTDF's ROE is +2.34%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, VPTDF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MEDGF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, VPTDF is priced at $0.09, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, VPTDF's ROE is +2.34%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, VPTDF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DRWKF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DRWKF has a market cap of 1.25B. Regarding current trading prices, VPTDF is priced at $0.09, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DRWKF's P/E ratio is 9.05. In terms of profitability, VPTDF's ROE is +2.34%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, VPTDF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DGWPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DGWPF has a market cap of 1.18B. Regarding current trading prices, VPTDF is priced at $0.09, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DGWPF's P/E ratio is 7.67. In terms of profitability, VPTDF's ROE is +2.34%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, VPTDF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs XVIPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, VPTDF is priced at $0.09, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, VPTDF's ROE is +2.34%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, VPTDF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs LFTSF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, VPTDF is priced at $0.09, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, VPTDF's ROE is +2.34%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, VPTDF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ELEAF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, VPTDF is priced at $0.09, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ELEAF's P/E ratio is 12.08. In terms of profitability, VPTDF's ROE is +2.34%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, VPTDF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MDRSF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, VPTDF is priced at $0.09, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, VPTDF's ROE is +2.34%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, VPTDF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CALZF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CALZF has a market cap of 586.53M. Regarding current trading prices, VPTDF is priced at $0.09, while CALZF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CALZF's P/E ratio is 84.90. In terms of profitability, VPTDF's ROE is +2.34%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, VPTDF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs AVMR Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, VPTDF is priced at $0.09, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas AVMR's P/E ratio is -18.34. In terms of profitability, VPTDF's ROE is +2.34%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, VPTDF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CLVSF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, VPTDF is priced at $0.09, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, VPTDF's ROE is +2.34%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, VPTDF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs IOBCF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, IOBCF has a market cap of 380.84M. Regarding current trading prices, VPTDF is priced at $0.09, while IOBCF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas IOBCF's P/E ratio is 37.14. In terms of profitability, VPTDF's ROE is +2.34%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, VPTDF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs HYBT Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, VPTDF is priced at $0.09, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas HYBT's P/E ratio is N/A. In terms of profitability, VPTDF's ROE is +2.34%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, VPTDF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs EAPIF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, VPTDF is priced at $0.09, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, VPTDF's ROE is +2.34%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, VPTDF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CSSPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, VPTDF is priced at $0.09, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, VPTDF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CLLKF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CLLKF has a market cap of 253.16M. Regarding current trading prices, VPTDF is priced at $0.09, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, VPTDF's ROE is +2.34%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, VPTDF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CYBQY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CYBQY has a market cap of 248.63M. Regarding current trading prices, VPTDF is priced at $0.09, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, VPTDF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs HTLZF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, VPTDF is priced at $0.09, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, VPTDF's ROE is +2.34%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, VPTDF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SNWV Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SNWV has a market cap of 244.26M. Regarding current trading prices, VPTDF is priced at $0.09, while SNWV trades at $28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SNWV's P/E ratio is -4.58. In terms of profitability, VPTDF's ROE is +2.34%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, VPTDF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs BCCOY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, VPTDF is priced at $0.09, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, VPTDF's ROE is +2.34%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, VPTDF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs IMPZY Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, VPTDF is priced at $0.09, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, VPTDF's ROE is +2.34%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, VPTDF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs AVHHL Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, VPTDF is priced at $0.09, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, VPTDF's ROE is +2.34%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, VPTDF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CYBQF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, VPTDF is priced at $0.09, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, VPTDF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs BRNHF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, VPTDF is priced at $0.09, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, VPTDF's ROE is +2.34%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, VPTDF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs EKDHF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, VPTDF is priced at $0.09, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, VPTDF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs JMDMF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, VPTDF is priced at $0.09, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, VPTDF's ROE is +2.34%, compared to JMDMF's ROE of N/A. Regarding short-term risk, VPTDF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs PXMBF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, PXMBF has a market cap of 146.32M. Regarding current trading prices, VPTDF is priced at $0.09, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, VPTDF's ROE is +2.34%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, VPTDF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs BRSYF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, VPTDF is priced at $0.09, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, VPTDF's ROE is +2.34%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, VPTDF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs AMEUF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, VPTDF is priced at $0.09, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, VPTDF's ROE is +2.34%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, VPTDF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs VMTHF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, VPTDF is priced at $0.09, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, VPTDF's ROE is +2.34%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, VPTDF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs FDMDF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, VPTDF is priced at $0.09, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, VPTDF's ROE is +2.34%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, VPTDF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs RSHUF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, VPTDF is priced at $0.09, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, VPTDF's ROE is +2.34%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, VPTDF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs CKMTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, VPTDF is priced at $0.09, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, VPTDF's ROE is +2.34%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, VPTDF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SOMNF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, VPTDF is priced at $0.09, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, VPTDF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DMTRF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, VPTDF is priced at $0.09, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, VPTDF's ROE is +2.34%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, VPTDF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs SNZZF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, VPTDF is priced at $0.09, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, VPTDF's ROE is +2.34%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, VPTDF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs RDGL Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, RDGL has a market cap of 60.54M. Regarding current trading prices, VPTDF is priced at $0.09, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas RDGL's P/E ratio is -13.35. In terms of profitability, VPTDF's ROE is +2.34%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, VPTDF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs BLOZF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, BLOZF has a market cap of 49.27M. Regarding current trading prices, VPTDF is priced at $0.09, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas BLOZF's P/E ratio is -21.39. In terms of profitability, VPTDF's ROE is +2.34%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, VPTDF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs IPDQF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, IPDQF has a market cap of 42.98M. Regarding current trading prices, VPTDF is priced at $0.09, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas IPDQF's P/E ratio is -2.12. In terms of profitability, VPTDF's ROE is +2.34%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, VPTDF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs NVYTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, VPTDF is priced at $0.09, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, VPTDF's ROE is +2.34%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, VPTDF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs TLTFF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, TLTFF has a market cap of 30.11M. Regarding current trading prices, VPTDF is priced at $0.09, while TLTFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas TLTFF's P/E ratio is -12.15. In terms of profitability, VPTDF's ROE is +2.34%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, VPTDF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ELXMF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, VPTDF is priced at $0.09, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, VPTDF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs PYNKF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, PYNKF has a market cap of 25.06M. Regarding current trading prices, VPTDF is priced at $0.09, while PYNKF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas PYNKF's P/E ratio is -1.35. In terms of profitability, VPTDF's ROE is +2.34%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, VPTDF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs KBBTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, VPTDF is priced at $0.09, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, VPTDF's ROE is +2.34%, compared to KBBTF's ROE of N/A. Regarding short-term risk, VPTDF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs POSC Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, POSC has a market cap of 22.56M. Regarding current trading prices, VPTDF is priced at $0.09, while POSC trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas POSC's P/E ratio is 0.38. In terms of profitability, VPTDF's ROE is +2.34%, compared to POSC's ROE of +9.25%. Regarding short-term risk, VPTDF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs EMITF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, VPTDF is priced at $0.09, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas EMITF's P/E ratio is -15.38. In terms of profitability, VPTDF's ROE is +2.34%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, VPTDF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ASAPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ASAPF has a market cap of 17.37M. Regarding current trading prices, VPTDF is priced at $0.09, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ASAPF's P/E ratio is -22.50. In terms of profitability, VPTDF's ROE is +2.34%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, VPTDF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DIZTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DIZTF has a market cap of 16.91M. Regarding current trading prices, VPTDF is priced at $0.09, while DIZTF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DIZTF's P/E ratio is -7.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, VPTDF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MDXHF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MDXHF has a market cap of 15.46M. Regarding current trading prices, VPTDF is priced at $0.09, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, VPTDF's ROE is +2.34%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, VPTDF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs TMDIF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, VPTDF is priced at $0.09, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, VPTDF's ROE is +2.34%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, VPTDF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs PLLWF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, VPTDF is priced at $0.09, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, VPTDF's ROE is +2.34%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, VPTDF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs IMEXF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, IMEXF has a market cap of 11.72M. Regarding current trading prices, VPTDF is priced at $0.09, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas IMEXF's P/E ratio is N/A. In terms of profitability, VPTDF's ROE is +2.34%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, VPTDF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ATBPF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, VPTDF is priced at $0.09, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, VPTDF's ROE is +2.34%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, VPTDF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs LXXGF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, VPTDF is priced at $0.09, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, VPTDF's ROE is +2.34%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, VPTDF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs RMSL Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, RMSL has a market cap of 11.21M. Regarding current trading prices, VPTDF is priced at $0.09, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas RMSL's P/E ratio is 0.73. In terms of profitability, VPTDF's ROE is +2.34%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, VPTDF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs NGMDF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, NGMDF has a market cap of 10.21M. Regarding current trading prices, VPTDF is priced at $0.09, while NGMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas NGMDF's P/E ratio is -0.01. In terms of profitability, VPTDF's ROE is +2.34%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, VPTDF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs GTHP Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, GTHP has a market cap of 9.47M. Regarding current trading prices, VPTDF is priced at $0.09, while GTHP trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas GTHP's P/E ratio is -2.40. In terms of profitability, VPTDF's ROE is +2.34%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, VPTDF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs IRME Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, VPTDF is priced at $0.09, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas IRME's P/E ratio is -4.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to IRME's ROE of +11.77%. Regarding short-term risk, VPTDF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs BIEL Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, BIEL has a market cap of 7.23M. Regarding current trading prices, VPTDF is priced at $0.09, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas BIEL's P/E ratio is N/A. In terms of profitability, VPTDF's ROE is +2.34%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, VPTDF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ALRTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ALRTF has a market cap of 6.35M. Regarding current trading prices, VPTDF is priced at $0.09, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ALRTF's P/E ratio is -0.33. In terms of profitability, VPTDF's ROE is +2.34%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, VPTDF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MKEAF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MKEAF has a market cap of 5.76M. Regarding current trading prices, VPTDF is priced at $0.09, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, VPTDF's ROE is +2.34%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, VPTDF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs DTXMF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, VPTDF is priced at $0.09, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, VPTDF's ROE is +2.34%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, VPTDF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs TBRIF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, TBRIF has a market cap of 5.68M. Regarding current trading prices, VPTDF is priced at $0.09, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas TBRIF's P/E ratio is -1.25. In terms of profitability, VPTDF's ROE is +2.34%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, VPTDF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs QLIS Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, VPTDF is priced at $0.09, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas QLIS's P/E ratio is 2.22. In terms of profitability, VPTDF's ROE is +2.34%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, VPTDF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs RHNMF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, VPTDF is priced at $0.09, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, VPTDF's ROE is +2.34%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, VPTDF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs MICR Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, VPTDF is priced at $0.09, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas MICR's P/E ratio is -3.47. In terms of profitability, VPTDF's ROE is +2.34%, compared to MICR's ROE of -0.25%. Regarding short-term risk, VPTDF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs PMEDF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, PMEDF has a market cap of 4.46M. Regarding current trading prices, VPTDF is priced at $0.09, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas PMEDF's P/E ratio is -2.97. In terms of profitability, VPTDF's ROE is +2.34%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, VPTDF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs FZMD Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, VPTDF is priced at $0.09, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas FZMD's P/E ratio is 1.20. In terms of profitability, VPTDF's ROE is +2.34%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, VPTDF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs NUMD Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, NUMD has a market cap of 4.34M. Regarding current trading prices, VPTDF is priced at $0.09, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas NUMD's P/E ratio is 5.20. In terms of profitability, VPTDF's ROE is +2.34%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, VPTDF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs LBLTF Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, VPTDF is priced at $0.09, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, VPTDF's ROE is +2.34%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, VPTDF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs VYCO Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, VPTDF is priced at $0.09, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas VYCO's P/E ratio is -12.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, VPTDF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ADMT Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ADMT has a market cap of 3.74M. Regarding current trading prices, VPTDF is priced at $0.09, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ADMT's P/E ratio is -5.53. In terms of profitability, VPTDF's ROE is +2.34%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, VPTDF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs VANIW Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, VPTDF is priced at $0.09, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas VANIW's P/E ratio is N/A. In terms of profitability, VPTDF's ROE is +2.34%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, VPTDF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs USAQ Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, USAQ has a market cap of 2.88M. Regarding current trading prices, VPTDF is priced at $0.09, while USAQ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas USAQ's P/E ratio is -6.38. In terms of profitability, VPTDF's ROE is +2.34%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, VPTDF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.
VPTDF vs ESMC Comparison
VPTDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VPTDF stands at 15.00M. In comparison, ESMC has a market cap of 2.60M. Regarding current trading prices, VPTDF is priced at $0.09, while ESMC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VPTDF currently has a P/E ratio of -4.59, whereas ESMC's P/E ratio is 7.00. In terms of profitability, VPTDF's ROE is +2.34%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, VPTDF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for VPTDF.